Aevitas Wealth Management Inc. acquired a new position in shares of Clorox Co (NYSE:CLX) in the 4th quarter, Holdings Channel reports. The fund acquired 10,468 shares of the company’s stock, valued at approximately $1,557,000. Clorox accounts for about 1.5% of Aevitas Wealth Management Inc.’s portfolio, making the stock its 18th largest position.
A number of other hedge funds have also recently modified their holdings of CLX. Amalgamated Bank raised its holdings in shares of Clorox by 9.6% in the fourth quarter. Amalgamated Bank now owns 16,931 shares of the company’s stock worth $2,518,000 after acquiring an additional 1,482 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Clorox by 2,402.3% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 25,023 shares of the company’s stock worth $3,722,000 after acquiring an additional 24,023 shares during the last quarter. Quadrature Capital Ltd acquired a new position in shares of Clorox in the fourth quarter worth $2,869,000. Sheaff Brock Investment Advisors LLC acquired a new position in shares of Clorox in the fourth quarter worth $246,000. Finally, Standard Life Aberdeen plc raised its holdings in shares of Clorox by 1.9% in the fourth quarter. Standard Life Aberdeen plc now owns 36,918 shares of the company’s stock worth $5,492,000 after acquiring an additional 675 shares during the last quarter. 74.11% of the stock is owned by hedge funds and other institutional investors.
A number of research firms have recently weighed in on CLX. Zacks Investment Research raised Clorox from a “hold” rating to a “buy” rating and set a $161.00 price target for the company in a report on Wednesday, January 24th. BMO Capital Markets set a $147.00 price target on Clorox and gave the stock a “buy” rating in a report on Monday, February 5th. Morgan Stanley cut their price target on Clorox from $140.00 to $133.00 and set an “equal weight” rating for the company in a report on Monday, February 5th. Bank of America cut their price target on Clorox from $155.00 to $140.00 and set a “neutral” rating for the company in a report on Monday, February 5th. Finally, Argus cut Clorox from a “buy” rating to a “hold” rating and cut their price target for the stock from $150.40 to $127.81 in a report on Thursday, February 8th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the company’s stock. Clorox currently has a consensus rating of “Hold” and an average price target of $132.46.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Friday, February 2nd. The company reported $1.23 EPS for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 earnings per share. analysts expect that Clorox Co will post 6.23 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Stockholders of record on Wednesday, April 25th will be given a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, April 24th. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.95%. This is an increase from Clorox’s previous quarterly dividend of $0.84. Clorox’s payout ratio is currently 55.81%.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.